DOJ's Novel Cybersecurity FCA Case Is A Warning To Medtech
The U.S. Department of Justice's first-of-its-kind settlement with Illumina Inc. involved alleged cybersecurity deficiencies causing violations of the False Claims Act based on U.S. Food and Drug Administration quality standards....To view the full article, register now.
Already a subscriber? Click here to view full article